Ph.D. Innovation Program Student Testimonials

Dartmouth engineer Michael Balch discusses what drew him to Dartmouth's PhD Innovation Program, and the unique access this program has given him to important industry contacts and research. Faculty advisor: Lee Lynd

Dartmouth engineering student Regina Salvat discusses why she chose the PhD Innovation Program and her research in de-immunizing therapeutic proteins for cancer therapy. Faculty advisor: Karl Griswold

Dartmouth engineering student Austin Boesch talks about why he chose the PhD Innovation Program and his research on developing more potent vaccine immunogens and antibody therapies. Faculty advisor: Margie Ackerman

Dartmouth engineering student Zhiyuan Wang talks about why he chose the PhD Innovation Program and his research in integrated photonics. Faculty advisor: Jifeng Liu

Dartmouth engineering student Steven Reinitz '09 Th'09 discusses his IV-line sterilization device for preventing hospital-acquired infections and why he chose the PhD Innovation Program as well as founding his company, B.B.R. Medical Innovations Inc. Faculty advisor: Douglas Van Citters

Dartmouth engineering student Song Chen discusses why he chose the PhD Innovation Program and his research in digital integration sensors. Faculty advisor: Eric Fossum

Dartmouth engineering student Harrison Hall discusses why he chose the PhD Innovation Program and his research in real-time visualization of joint positioning in the in-situ environment using sensors, cell phones, and artificial learning techniques. Faculty advisor: Laura Ray

Dartmouth engineering student Daniel Harburg—Dual Degree '06 Th'09—discusses why he chose the PhD Innovation Program and his research on designing and building micro-scale magnetic components for electrical power conversion systems. Faculty advisor: Charles Sullivan

Dartmouth engineering student Alicia Petryk '06 Th'07 '08 '13 discusses why she chose the PhD Innovation Program and her work with developing iron-oxide nanoparticles—very small crystals of iron oxide in a biocompatible coding—as a cancer therapy. Faculty advisor: Jack Hoopes

Andrew Giustini DMS'10 Th'12, MD/PhD, describes how he chose the program to give him the tools he needs to bring therapeutics to clinical use:

Preston Manwaring Th'13 discusses how the program enabled him both to expand the applications of his medical imaging research, and to develop the essential entrepreneurial skills and networks:

Ashifi Gogo Th'09 founder of Sproxil, Inc. (formerly mPedigree), tells how the program curriculum taught him how to develop his research into a viable technology for combatting counterfeit drugs in developing countries: